Role of Antidepressants in Acute Coronary Syndrome: An Evidence-Based Case Report

Hamzah Shatri, Nabella Qisthina Laksita Dewi, Vinandia Irvianita, Edward Faisal, Rudi Putranto

Abstract


Background: Acute coronary syndrome (ACS) and depression are related to each other. Detection and proper treatment of these conditions can improve functional ability and quality of life. However, there is still controversy in this population regarding the use, safety, and efficacy of antidepressant pharmacotherapy. This evidence-based case report (EBCR) aims to determine the role of antidepressants in acute coronary syndrome patients. Methods: Literature searching was performed using online databases such as EBSCO, Embase, PubMed, ClinicalKey, and ScienceDirect according to clinical questions. The studies were selected based on the suitability of the inclusion and exclusion criteria followed by critical appraisal. Results: In patients with ACS, antidepressants do not affect mortality but may reduce rehospitalization. In patients with ACS and depression who received antidepressants, there is a reduced risk of myocardial infarction (MI) recurrence. In post-ACS patients, the use of antidepressants is associated with a reduced risk of recurrent MI. Conclusion: In ACS patients, antidepressants do not affect mortality, but can reduce the incidence of myocardial reinfarction.


Keywords


acute coronary syndrome; antidepressant; cardiovascular event; mortality

References


Fehr N, Witassek F, Radovanovic D, Erne P, Puhan M, Rickli H. Antidepressant prescription in acute myocardial infarction is associated with increased mortality 1 year after discharge. European Journal of Internal Medicine. 2019;61:75–80.

Christiansen OG, Madsen MT, Simonsen E, Gögenur I. Prophylactic antidepressant treatment following acute coronary syndrome: A systematic review of randomized controlled trials. Journal of Psychiatric Research. 2017;94:186–93.

Kang HJ, Bae KY, Kim SW, et al. Effects of escitalopram on anxiety in patients with acute coronary syndrome: A randomized controlled trial. Clinical Psychopharmacology and Neuroscience. 2017;15(2):126–31.

Kim JM, Stewart R, Lee YS, et al. Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: A randomized clinical trial. JAMA. 2018;320(4):350–7.

Fernandes N, Prada L, Rosa MM, et al. The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis. Clinical Research in Cardiology. 2021;110(2):183–93.

Sweda R, Siontis GCM, Nikolakopoulou A, Windecker S, Pilgrim T. Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian meta-analysis. ESC Heart Failure. 2020;7(6):3610–20.

Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894-8.


Full Text: PDF

Refbacks

  • There are currently no refbacks.